​

Theravance Biopharma Ownership | Who Owns Theravance Biopharma?

OverviewForecastRevenueFinancialsChartTranscripts

Theravance Biopharma Ownership Summary

Theravance Biopharma is owned by 21.18% institutional investors, 4.23% insiders, and 74.59% retail investors. Madison avenue partners, lp is the largest institutional shareholder, holding 18.96% of TBPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.26% of its assets in Theravance Biopharma shares.

TBPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTheravance Biopharma21.18%4.23%74.59%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Madison avenue partners, lp9.51M18.96%$138.86M
Weiss asset management lp7.46M14.86%$108.87M
Newtyn management4.95M9.87%$72.27M
Blackrock funding, inc. /de4.07M8.11%$59.41M
Blackrock3.78M7.83%$32.06M
Irenic capital management lp2.76M5.50%$40.31M
Vanguard group2.21M4.41%$32.29M
Park west asset management1.28M2.56%$18.75M
Oasis management1.12M2.23%$16.34M
Acadian asset management1.09M2.17%$15.90M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Newtyn management4.95M8.85%$72.27M
Madison avenue partners, lp9.51M8.29%$138.86M
Irenic capital management lp2.76M4.22%$40.31M
Park west asset management1.28M1.58%$18.75M
Oasis management1.12M1.57%$16.34M
Weiss asset management lp7.46M1.32%$108.87M
Camber capital management lp450.00K0.47%$4.96M
Militia capital partners, lp54.20K0.37%$791.32K
Longboard asset management, lp13.10K0.31%$191.29K
Corton capital33.35K0.18%$313.79K

Top Buyers

HolderShares% AssetsChange
Acadian asset management1.09M0.03%780.73K
Arrowstreet capital, limited partnership726.78K0.01%726.78K
Assenagon asset management414.71K0.01%390.74K
Hillsdale investment management310.70K0.14%310.70K
Marshall wace, llp357.65K0.01%256.87K

Top Sellers

HolderShares% AssetsChange
Baupost group llc/ma---4.20M
Pictet asset management sa---684.89K
Camber capital management lp450.00K0.47%-550.00K
Park west asset management1.28M1.58%-515.00K
Royal bank of canada8.44K--495.18K

New Positions

HolderShares% AssetsChangeValue
Hillsdale investment management310.70K0.14%310.70K$4.54M
Algert global199.71K0.05%199.71K$2.92M
Man group79.79K0.00%79.79K$1.16M
Winton group76.54K0.04%76.54K$1.12M
Inspire investing73.56K0.10%73.56K$1.07M

Sold Out

HolderChange
True wealth design-3.00
Capital performance advisors llp-5.00
Nelson, van denburg & campbell wealth management group-13.00
Lindbrook capital-14.00
Corecap advisors-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202570-48.53%10,629,292-77.11%210.24%37-52.56%14-56.25%
Jun 30, 20251352.27%46,426,0143.43%931.15%7732.76%32-31.91%
Mar 31, 20251333.10%44,910,1350.05%901.08%59-10.61%4845.45%
Dec 31, 202446-61.98%6,919,684-84.88%140.16%23-56.60%11-73.17%
Sep 30, 2024121-9.02%45,773,807-2.84%931.00%53-22.06%41-8.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.14M2.26%-25.24K
Vanguard US Total Market Shares ETF1.07M2.15%-
iShares Russell 2000 ETF923.09K1.83%-
Pictet Biopharmaceutical Mother652.30K1.32%-349.81K
Vanguard Institutional Extnd Mkt Idx Tr388.76K0.77%-167.02K
Fidelity Small Cap Index379.30K0.75%4.28K
iShares Russell 2000 Value ETF336.22K0.67%-
State St Russell Sm/Mid Cp® Indx NL Cl C330.21K0.66%958.00
State St Russell Sm/Mid Cp® Indx SL Cl I330.21K0.66%-
CREF Stock R1308.81K0.62%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 03, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$291.25K
Dec 03, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$145.63K
Dec 03, 2025Farnum Rhonda SVP, COMM & MEDICAL AFFAIRSSell$145.62K
Nov 26, 2025BROSHY ERAN-Sell$280.00K
Nov 26, 2025BROSHY ERAN-Sell$310.02K

Insider Transactions Trends

DateBuySell
2025 Q4-11
2025 Q3-3
2025 Q2-2
2025 Q1-1
2024 Q4-1

TBPH Ownership FAQ

Who Owns Theravance Biopharma?

Theravance Biopharma shareholders are primarily institutional investors at 21.18%, followed by 4.23% insiders and 74.59% retail investors. The average institutional ownership in Theravance Biopharma's industry, Biotech Stocks , is 45.22%, which Theravance Biopharma falls below.

Who owns the most shares of Theravance Biopharma?

Theravance Biopharma’s largest shareholders are Madison avenue partners, lp (9.51M shares, 18.96%), Weiss asset management lp (7.46M shares, 14.86%), and Newtyn management (4.95M shares, 9.87%). Together, they hold 43.68% of Theravance Biopharma’s total shares outstanding.

Does Blackrock own Theravance Biopharma?

Yes, BlackRock owns 7.83% of Theravance Biopharma, totaling 3.78M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 32.06M$. In the last quarter, BlackRock decreased its holdings by -428K shares, a -10.17% change.

Who is Theravance Biopharma’s biggest shareholder by percentage of total assets invested?

Newtyn management is Theravance Biopharma’s biggest shareholder by percentage of total assets invested, with 8.85% of its assets in 4.95M Theravance Biopharma shares, valued at 72.27M$.

Who is the top mutual fund holder of Theravance Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Theravance Biopharma shares, with 2.26% of its total shares outstanding invested in 1.14M Theravance Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools